Logo image of CHCI

COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

NASDAQ:CHCI - Nasdaq - US2056842022 - Common Stock - Currency: USD

9.25  +0.06 (+0.65%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CHCI. CHCI was compared to 65 industry peers in the Real Estate Management & Development industry. CHCI gets an excellent profitability rating and is at the same time showing great financial health properties. CHCI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

CHCI had positive earnings in the past year.
CHCI had a positive operating cash flow in the past year.
CHCI had positive earnings in each of the past 5 years.
In the past 5 years CHCI always reported a positive cash flow from operatings.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of 24.26%, CHCI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CHCI has a Return On Equity of 28.37%. This is amongst the best in the industry. CHCI outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.78%, CHCI belongs to the top of the industry, outperforming 98.46% of the companies in the same industry.
CHCI had an Average Return On Invested Capital over the past 3 years of 18.89%. This is significantly above the industry average of 5.45%.
Industry RankSector Rank
ROA 24.26%
ROE 28.37%
ROIC 15.78%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

With an excellent Profit Margin value of 28.59%, CHCI belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
In the last couple of years the Profit Margin of CHCI has grown nicely.
CHCI has a better Operating Margin (20.40%) than 87.69% of its industry peers.
In the last couple of years the Operating Margin of CHCI has grown nicely.
The Gross Margin of CHCI (24.89%) is comparable to the rest of the industry.
CHCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.4%
PM (TTM) 28.59%
GM 24.89%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHCI is creating value.
CHCI has more shares outstanding than it did 1 year ago.
CHCI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CHCI has an Altman-Z score of 4.81. This indicates that CHCI is financially healthy and has little risk of bankruptcy at the moment.
CHCI has a Altman-Z score of 4.81. This is amongst the best in the industry. CHCI outperforms 81.54% of its industry peers.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.81
ROIC/WACC1.74
WACC9.05%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 4.16 indicates that CHCI has no problem at all paying its short term obligations.
CHCI's Current ratio of 4.16 is amongst the best of the industry. CHCI outperforms 84.62% of its industry peers.
CHCI has a Quick Ratio of 4.16. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
CHCI has a Quick ratio of 4.16. This is amongst the best in the industry. CHCI outperforms 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 4.16
Quick Ratio 4.16
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

CHCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.59%, which is quite impressive.
The Earnings Per Share has been growing by 61.08% on average over the past years. This is a very strong growth
CHCI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.03%.
CHCI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)86.59%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%71.28%
Revenue 1Y (TTM)18.03%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%18.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.34, the valuation of CHCI can be described as very cheap.
93.85% of the companies in the same industry are more expensive than CHCI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.25. CHCI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.34
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHCI is valued cheaper than 96.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHCI is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.08
EV/EBITDA 5.8
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The excellent profitability rating of CHCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHCI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (5/30/2025, 8:00:00 PM)

9.25

+0.06 (+0.65%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-06 2025-08-06
Inst Owners7.54%
Inst Owner Change-0.84%
Ins Owners65.64%
Ins Owner Change2.12%
Market Cap93.15M
Analysts0
Price TargetN/A
Short Float %0.55%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.34
Fwd PE N/A
P/S 1.75
P/FCF 7.08
P/OCF 6.9
P/B 1.73
P/tB 1.74
EV/EBITDA 5.8
EPS(TTM)1.46
EY15.78%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.31
FCFY14.13%
OCF(TTM)1.34
OCFY14.49%
SpS5.29
BVpS5.33
TBVpS5.32
PEG (NY)N/A
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 24.26%
ROE 28.37%
ROCE 19.98%
ROIC 15.78%
ROICexc 32.87%
ROICexgc 33.12%
OM 20.4%
PM (TTM) 28.59%
GM 24.89%
FCFM 24.69%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
ROICexc(3y)36.53%
ROICexc(5y)31.24%
ROICexgc(3y)36.83%
ROICexgc(5y)32.34%
ROCE(3y)23.91%
ROCE(5y)20.74%
ROICexcg growth 3Y10.99%
ROICexcg growth 5Y13.58%
ROICexc growth 3Y10.68%
ROICexc growth 5Y17.17%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
F-Score5
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 108.28%
Cap/Sales 0.64%
Interest Coverage 250
Cash Conversion 120.65%
Profit Quality 86.34%
Current Ratio 4.16
Quick Ratio 4.16
Altman-Z 4.81
F-Score5
WACC9.05%
ROIC/WACC1.74
Cap/Depr(3y)179.46%
Cap/Depr(5y)167.67%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.78%
Profit Quality(3y)87.69%
Profit Quality(5y)95.22%
High Growth Momentum
Growth
EPS 1Y (TTM)86.59%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%71.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.03%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%18.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.92%
EBIT growth 3Y26.35%
EBIT growth 5Y34.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.75%
FCF growth 3Y10.69%
FCF growth 5Y4.68%
OCF growth 1Y75.3%
OCF growth 3Y11.03%
OCF growth 5Y4.91%